International Clinical Neuroscience Journal

Wrensch M, Minn Y, Chew T. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278–99.

Denham SA, Brown CA, Domitrovich CE. “Plays nice with others”: Social-emotional learning and academic success. In special issue, H. Teglasi (Ed.), Overlaps between socio-emotional and academic development, Early Education and Development. 2010;21:652-680.

Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncology. 2000;2:221–228.

Mainio A, Hakko H, Niemela A, Tuurinkoski T, Koivukangas J, Rasanen P. The effect of brain tumour laterality on anxiety levels among neurosurgical patients. J Neurol Neurosurg Psychiatry. 2003;74:1278–1282.

Cummings JL. Neuropsychiatric manifestations of right hemisphere lesions. Brain Lang. 1997;57:22–37

Taphoorn MJ, Schiphorst AK, Snoek FJ, Lindeboom J, Wolbers JG, Karim AB, et al, Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol. 1994;36:48–54.

Gustafsson M. Edvardsson T. Ahlstrom G. The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer. 2006;14:1205–1212.

Bhat SR1, Goodwin TL, Burwinkle TM, Lansdale MF, Dahl GV, Huhn SL, et al. Profile of daily life in children with brain tumors: An assessment of health-related quality of life. J Clin Oncol. 2005;23:5493-5500,

Weitzner MA1, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75:1151–1161.

Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008 Jul 31;359(5):492-507.

Meyers CA, Hess KR, Yung WK, Levin VA. Cognitive functions as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000;18:646–650

Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76:562–568.

Meyers CA. Hess KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro- Oncology. 2003;5:89–95

Klein M1, Postma TJ, Taphoorn MJ, Aaronson NK, Vandertop WP, Muller M, et al. The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology. 2003;61:1796–1798.

Fox S. Lyon D, Farace E. Symptom clusters in patients with high – grade glioma. Journal of Clinical Scholarship. 2007;39(1):61– 67.

Litofsky N, Farace E, Anderson F, Meyers C, Huang W, Laws E. Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery. 2004;54:358-367.

Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256:516–21.

Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 2005;56:1234–41.

North CA, North RB, Epstein JA, Piantadosi S, Wharam MD. Low grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer. 1990;66:6–14.

Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor pa¬tients: the relative contributions of depression, fatigue, emotional distress, and existential is¬sues. J Neurooncology. 2002;57:41–49.

Van Den Bent MJ, Afra D. De, Witte O. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366:985–90.

Armstrong T, Cohen MZ, Hess KR. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J Pain Symptom Manage. 2006;32:148–154.

Kaleita TA, Wellisch DK, Graham CA, Steh P, Nghiemphu JM, Ford A, et al.Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. J Clin Oncol. 2006;24:1503.

Walker M, Brown J, Brown K, Gregor A, Whittle IR, Grant R. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol. 2003;63:179–186.

Mainio A, Hakko H, Niemela A. Gender difference in relation to depression and quality of life among patients with a primary brain tumour. European Psychiatry: the journal of the Association of European Psychiatrists. 2006;21(3):194–9.

Brown PD, Maurer MJ, Rummans TA. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57:495–504.

Jenkins CA, Bruera E. Difficulties in diagnosing neuropsychiatric complications of corticosteroids in advanced cancer patients: two case reports. J Pain Symptom Manage. 2000;19:309–317.

Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Sch. 2004;36:197–206.

Folstein M, Folstein SE, McHugh PR.“Mini-Mental State” a Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research. 1975;12(3);189-198.

Orley J. WHO meeting on quality of life: development of the WHOQOL instrument.quality of life news; 1992.

Sheline GE, Warra W, Smith V. Therapeutic irradiation and brain injury. International Journal of Radiation Oncology and Biological Physics. 1980;6:1215–1228.

Irle E, Peper M, Wowra B, Kunze S. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol. 1994; 51:164–174.

Giovagnoli AR, Tamburini M, Boiardi A. Quality of life in brain tumor patients. J Neurooncol. 1996;30:71–80.

Kaplan, CP. Miner, ME. Relationships: importance for patients with cerebral tumours. Brain Inj. 2000;14:251–259.

Arnold, SD. Forman, LM. Brigidi, BD. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro-Oncology. 2008;10:171–181.

Zarghi A, Zali A, Ashrafi F, Moazezi M. Neuroscience and Neuro-cognitive Rehabilitation. Basic Research Journal of Medicine and Clinical Sciences. 2013a;2(8),83-87.

Zarghi A, Zali A, Ashrafi F, Moazezi M. Emotional, behavioral and cognitive mechanisms in rehabilitation of romantic love neuro-cognitive process. Basic Research Journal of Medicine and Clinical Sciences. 2013b; (9):94-102.

Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Khodadadi M. Comparative assessment of neuro-cognitive impairments among patients with brain tumor and healthy adults. Turkish Neurosurgery. 2012a;22:309-316.

Zarghi A, Zali A, Tehranidost M, Ashrafi F, Zarindast M.R, Moazezi M, et al. Assessment of Selective Attention With CSCWT (Computerized Stroop Color-Word Test) Among Children and Adults, US-China Education Review A. 2012b;1:121-127.

Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Doroodgar S, et al. The Relationship between Age, Sex and Education Variables with Selective, Sustained Attention and Planning through Cognitive Tasks among Healthy Adults. Basic and Clinical Neuroscience. 2011;2(3):58-67.